Referral Optimization AF Resource Center
Referring audiences (i.e. general cardiologists, primary care physicians, nurse practitioners, etc.) are instrumental in the care and treatment of paroxysmal atrial fibrillation (PAF) patients. Use the tools and resources below to educate and partner with referring networks to identify indicated PAF patients who may benefit from catheter ablation.
Watch this video for a brief message about how cardiologist and EP relationships can jointly address the growing challenge of AF. Scroll down to view the complete webinar.
View the full-length webinar on YouTube. If this message is meaningful to you and you would like to partner with one of your referring cardiologists to present to your hospital system or community, please contact your Medtronic Sales Representative today.
Audience: Referring Cardiologists
Use this tool to help evaluate your existing referral base and identify the best opportunity for locating indicated AF patients.
For more information and additional resources to help educate cardiologists in your community, contact your Medtronic Sales Representative to access the following:
REFERRAL EDUCATION POWERPOINT PRESENTATION
Show the prevalence of PAF, risks, and clinical evidence associated with radiofrequency ablation and cryoballoon treatment options.
JOINTLY ADDRESSING THE GROWING AF CHALLENGE POWERPOINT PRESENTATION
Featured in the webinar above, this presentation is designed to highlight how a cardiologist and EP work together to optimize AF patient care. Typically, this presentation is delivered by an EP and his/her referring cardiologist to a group of cardiologists.
Packer DL, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713-23.
Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010 Jan 27;303(4):333-40.